Literature DB >> 17318273

Surgery in rheumatoid arthritis patients under anti-TNF-alpha therapy: what is the risk?

Daniel Wendling.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17318273     DOI: 10.1007/s10067-007-0585-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  6 in total

1.  Tumour necrosis factor alpha antagonists and early postoperative complications in patients with inflammatory joint disease undergoing elective orthopaedic surgery.

Authors:  S C Talwalkar; D M Grennan; J Gray; P Johnson; M J Hayton
Journal:  Ann Rheum Dis       Date:  2005-04       Impact factor: 19.103

2.  Surgery in patients receiving anti-tumour necrosis factor alpha treatment in rheumatoid arthritis: an observational study on 50 surgical procedures.

Authors:  D Wendling; J-C Balblanc; A Brousse; A Lohse; G Lehuede; P Garbuio; E Toussirot; B Auge; D Jacques
Journal:  Ann Rheum Dis       Date:  2005-09       Impact factor: 19.103

3.  Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in rheumatoid arthritis.

Authors:  Jon T Giles; Susan J Bartlett; Allan C Gelber; Shikha Nanda; Kevin Fontaine; Victoria Ruffing; Joan M Bathon
Journal:  Arthritis Rheum       Date:  2006-04-15

4.  Safety of etanercept therapy in rheumatoid patients undergoing surgery: preliminary report.

Authors:  Salvatore Corrao; Giovanni Pistone; Sabrina Arnone; Luigi Calvo; Rosario Scaglione; Giuseppe Licata
Journal:  Clin Rheumatol       Date:  2007-01-17       Impact factor: 2.980

5.  Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery.

Authors:  D M Grennan; J Gray; J Loudon; S Fear
Journal:  Ann Rheum Dis       Date:  2001-03       Impact factor: 19.103

6.  Infectious and healing complications after elective orthopaedic foot and ankle surgery during tumor necrosis factor-alpha inhibition therapy.

Authors:  Christopher Bibbo; Jerry W Goldberg
Journal:  Foot Ankle Int       Date:  2004-05       Impact factor: 2.827

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.